Amphotericin B colloidal dispersion - ALZA

Drug Profile

Amphotericin B colloidal dispersion - ALZA

Alternative Names: ABCD; Amphocil; Amphotec; Amphotericin B cholesteryl sulfate; Amphotericin B cholesteryl sulfate complex; amphotericin B cholesteryl sulfate complex for injection; Amphotericin B liposomal - ALZA

Latest Information Update: 14 Sep 2015

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator ALZA Corporation
  • Class Antifungals; Macrolides
  • Mechanism of Action Cell membrane permeability enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Aspergillosis; Mycoses; Visceral leishmaniasis

Most Recent Events

  • 29 Apr 2016 Biomarkers information updated
  • 03 Sep 2015 Hospira has been acquired by Pfizer
  • 25 Oct 2010 Three Rivers Pharmaceuticals has been acquired by Kadmon Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top